Esperion Therapeutics | ESPR - Market Capitalization


Esperion Therapeutics reported $576.4M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Alterity Therapeutics Limited AUD 40M 16M May/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 189.89B 13.64B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.57B 290M May/2026
Cipla INR 1.22T 6.47B Dec/2025
CSL USD 55.89B 20.42B Dec/2025
Cytokinetics USD 9.25B 1.48B May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Geron USD 843M 31M Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Moderna USD 20.15B 8.53B Mar/2026
Nektar Therapeutics USD 15.62B 14.76B May/2026
Pfizer USD 148.08B 6.51B May/2026
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024